Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...
Andrew Fein, an analyst from H.C. Wainwright, reiterated the Hold rating on Fulcrum Therapeutics (FULC – Research Report). The associated ...
50% of patients (3/6) with baseline HBsAg <1000 IU/mL achieved a functional cure (defined as sustained HBsAg loss and HBV DNA less than the lower limit of quantification (LLOQ) 24 weeks off all ...
HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved functional ...
A new device out of LSU can detect where cancer cells end and healthy tissues begin. Here's what it means for health outcomes ...
The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by Viatris an ...
Women have been speaking about pre-menstrual syndrome from decades, but could men be experiencing the same cycle? We asked ...
Doctors at Zuckerberg San Francisco General Hospital are using a cutting-edge AI tool to analyze medical scans, helping them ...
Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...
Violence alcohol - Nora de Bode considers a new review on the national and regional prevalence of interpersonal violence from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback